May 1, 2014 2 min read

The first quarter was perfect medicine for Mylan Inc.

Mylan, the generic drug firm based at Southpointe, announced Thursday morning its net income for the first three months of this year increased by 8 percent from the first quarter of 2013. Income went from $106.9 million to $115.9 million during the respective quarters.

Revenue for the first quarter this year also rose from the previous year – to $1.72 billion from $1.63 billion, or 5 percent. Sales of antiretroviral drugs in India was a major factor.

Per-share profits also increased year over year, to 29 cents from 27 cents, or 5 percent.

In other first-quarter news:

• Ansys, a global provider of engineering simulation software also based at Southpointe, reported a record revenue of $215.3 million. That is 8.9 percent above the $197.7 million during the first quarter of 2013.

Net income for the past quarter was $56.5 million (60 cents per share), a 10.7 percent rise from $51 million (54 cents per share) for the same period of 2013.

• FedFirst Financial Corporation, the Monessen-based parent company of First Federal Savings Bank, reported a net income of $534,000 for the first quarter, a 32.7 percent decrease from $794,000 for the same quarter of 2013. Diluted earnings were $0.23 per share for the past quarter, down 28.1 percent from $0.32 for the first three months of 2013.

“Net income for the quarter increased compared to the fourth quarter of 2013 and, although it decreased in comparison to the first quarter of 2013, the prior year results were largely influenced by the receipt of contingency fees on insurance policies,” said Pat O’Brien, president and chief executive officer, said in a statement.